Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles
Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on...
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular pharmacology 1988-04, Vol.11 (4), p.407-412 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 412 |
---|---|
container_issue | 4 |
container_start_page | 407 |
container_title | Journal of cardiovascular pharmacology |
container_volume | 11 |
creator | Hattori, Yoshikazu Hidaka, Toshinori Aisaka, Kazuo Satoh, Fumio Ishihara, Takafumi |
description | Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively. |
doi_str_mv | 10.1097/00005344-198804000-00005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78236322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78236322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</originalsourceid><addsrcrecordid>eNqFks2O0zAUhS0EGkrhEZC8QKwmg3_jZFlKYRCjgoBhGznODQnj2h3bUemj8LYkNHSH8MbyOd-91_IxQpiSK0pK9YqMS3IhMloWBRHjKfsjPUALKjnPBGH8IVoQmpOMCZE_Rk9i_EEIFVLlF-iCCcmV4Av0a9O2YBL2Lf5yu8WU5vISa7yFA_7kE7iEVy71OoTumLpdb_Dq-yheYu9w6gB_6B2k3sSp_rNOkL2BPbhmqnttvbmb9K3G6047BzZi7Rr8bXRDbwarA1571wwm9WO7kdz8TEHHY0zeQnyKHrXaRng270t0-3bzdX2d3Xx89369usmM5FRmTJat0g1raVtDUxAqRa3yhoNkumagdF4y3eS1ULIgLCeyhPHlSkPLUhRyBJfo5anvPvj7AWKqdn00YK124IdYqYLxnDP2X5BKSiknE1icQBN8jAHaah_6nQ7HipJqiq_6G191jm-Wluj5PGOod9CcC-e8Rv_F7OtotG2DdqaPZ0zJUjI13UCcsIO3CUK8s8MBQtWBtqmr_vV5-G-f6LBW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15111302</pqid></control><display><type>article</type><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</creator><creatorcontrib>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</creatorcontrib><description>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-198804000-00005</identifier><identifier>PMID: 2453743</identifier><identifier>CODEN: JCPCDT</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Animals ; Anti-Arrhythmia Agents - pharmacology ; antiarrhythmic agents ; Antiarythmic agents ; Benzeneacetamides ; Biological and medical sciences ; Cardiac Complexes, Premature - physiopathology ; cardiac muscle ; Cardiovascular system ; Disopyramide - pharmacology ; Guinea Pigs ; Heart Conduction System - drug effects ; Heart Ventricles - drug effects ; In Vitro Techniques ; Ion Channels - drug effects ; Lidocaine - analogs & derivatives ; Lidocaine - pharmacology ; Male ; Medical sciences ; Mexiletine - pharmacology ; Papillary Muscles - drug effects ; Pharmacology. Drug treatments ; Piperidines - pharmacology ; sodium ; Sodium - metabolism</subject><ispartof>Journal of cardiovascular pharmacology, 1988-04, Vol.11 (4), p.407-412</ispartof><rights>Lippincott-Raven Publishers.</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf><![CDATA[$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&PDF=y&D=ovft&AN=00005344-198804000-00005$$EPDF$$P50$$Gwolterskluwer$$H]]></linktopdf><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005344-198804000-00005$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,780,784,4609,27924,27925,64666,65461</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7595272$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2453743$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hattori, Yoshikazu</creatorcontrib><creatorcontrib>Hidaka, Toshinori</creatorcontrib><creatorcontrib>Aisaka, Kazuo</creatorcontrib><creatorcontrib>Satoh, Fumio</creatorcontrib><creatorcontrib>Ishihara, Takafumi</creatorcontrib><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</description><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>antiarrhythmic agents</subject><subject>Antiarythmic agents</subject><subject>Benzeneacetamides</subject><subject>Biological and medical sciences</subject><subject>Cardiac Complexes, Premature - physiopathology</subject><subject>cardiac muscle</subject><subject>Cardiovascular system</subject><subject>Disopyramide - pharmacology</subject><subject>Guinea Pigs</subject><subject>Heart Conduction System - drug effects</subject><subject>Heart Ventricles - drug effects</subject><subject>In Vitro Techniques</subject><subject>Ion Channels - drug effects</subject><subject>Lidocaine - analogs & derivatives</subject><subject>Lidocaine - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mexiletine - pharmacology</subject><subject>Papillary Muscles - drug effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - pharmacology</subject><subject>sodium</subject><subject>Sodium - metabolism</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks2O0zAUhS0EGkrhEZC8QKwmg3_jZFlKYRCjgoBhGznODQnj2h3bUemj8LYkNHSH8MbyOd-91_IxQpiSK0pK9YqMS3IhMloWBRHjKfsjPUALKjnPBGH8IVoQmpOMCZE_Rk9i_EEIFVLlF-iCCcmV4Av0a9O2YBL2Lf5yu8WU5vISa7yFA_7kE7iEVy71OoTumLpdb_Dq-yheYu9w6gB_6B2k3sSp_rNOkL2BPbhmqnttvbmb9K3G6047BzZi7Rr8bXRDbwarA1571wwm9WO7kdz8TEHHY0zeQnyKHrXaRng270t0-3bzdX2d3Xx89369usmM5FRmTJat0g1raVtDUxAqRa3yhoNkumagdF4y3eS1ULIgLCeyhPHlSkPLUhRyBJfo5anvPvj7AWKqdn00YK124IdYqYLxnDP2X5BKSiknE1icQBN8jAHaah_6nQ7HipJqiq_6G191jm-Wluj5PGOod9CcC-e8Rv_F7OtotG2DdqaPZ0zJUjI13UCcsIO3CUK8s8MBQtWBtqmr_vV5-G-f6LBW</recordid><startdate>198804</startdate><enddate>198804</enddate><creator>Hattori, Yoshikazu</creator><creator>Hidaka, Toshinori</creator><creator>Aisaka, Kazuo</creator><creator>Satoh, Fumio</creator><creator>Ishihara, Takafumi</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198804</creationdate><title>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</title><author>Hattori, Yoshikazu ; Hidaka, Toshinori ; Aisaka, Kazuo ; Satoh, Fumio ; Ishihara, Takafumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5315-259f7ad2f1fbed80154b76d3e52ab2e7a692ad6b4758026059e0539c1994856d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>antiarrhythmic agents</topic><topic>Antiarythmic agents</topic><topic>Benzeneacetamides</topic><topic>Biological and medical sciences</topic><topic>Cardiac Complexes, Premature - physiopathology</topic><topic>cardiac muscle</topic><topic>Cardiovascular system</topic><topic>Disopyramide - pharmacology</topic><topic>Guinea Pigs</topic><topic>Heart Conduction System - drug effects</topic><topic>Heart Ventricles - drug effects</topic><topic>In Vitro Techniques</topic><topic>Ion Channels - drug effects</topic><topic>Lidocaine - analogs & derivatives</topic><topic>Lidocaine - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mexiletine - pharmacology</topic><topic>Papillary Muscles - drug effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - pharmacology</topic><topic>sodium</topic><topic>Sodium - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hattori, Yoshikazu</creatorcontrib><creatorcontrib>Hidaka, Toshinori</creatorcontrib><creatorcontrib>Aisaka, Kazuo</creatorcontrib><creatorcontrib>Satoh, Fumio</creatorcontrib><creatorcontrib>Ishihara, Takafumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hattori, Yoshikazu</au><au>Hidaka, Toshinori</au><au>Aisaka, Kazuo</au><au>Satoh, Fumio</au><au>Ishihara, Takafumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1988-04</date><risdate>1988</risdate><volume>11</volume><issue>4</issue><spage>407</spage><epage>412</epage><pages>407-412</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><coden>JCPCDT</coden><abstract>Effects of SUN 1165, disopyramide, lorcainide, and mexiletine were studied either on the kinetics of onset of and recovery from rate-dependent depression of maximum rate of rise of phase 0 action potential (Vmax) in isolated guinea pig papillary muscles using standard microelectrode techniques or on intraventricular conduction time of extrasystoles evoked at varied coupling intervals in anesthetized dogs. SUN 1165 and lorcainide produced a slow-developing rate-dependent block of Vmax with the rate constant of 0.12 AP-1 and 0.09 AP-1, respectively. Mexiletine also produced a rate-dependent block of Vmax, but with very rapid onset so as not to be fitted by a single exponential curve. Disopyramide produced an intermediate rate-dependent block of Vmax with the rate constant of 0.46 AP-1. The time constants for recovery from the rate-dependent block for SUN 1165, lorcainide and disopyramide were 27.3-28.2, 23.2, and 17.0 s, respectively, while that for mexiletine was 0.118 s. SUN 1165, lorcainide, and disopyramide slowed ventricular conduction time of extrasystoles at all coupling intervals of 800-250 ms. On the other hand, mexiletine slowed conduction time at short coupling intervals of 500-250 ms. These findings suggest that, like lorcainide, SUN 1165 belongs to class Ic antiarrhythmic agents, and that SUN 1165 and lorcainide as well as disopyramide with slow and intermediate kinetics and mexiletine with fast kinetics may inhibit ventricular extrasystoles conducted at long and short range of coupling intervals, respectively.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>2453743</pmid><doi>10.1097/00005344-198804000-00005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0160-2446 |
ispartof | Journal of cardiovascular pharmacology, 1988-04, Vol.11 (4), p.407-412 |
issn | 0160-2446 1533-4023 |
language | eng |
recordid | cdi_proquest_miscellaneous_78236322 |
source | MEDLINE; Journals@Ovid LWW Legacy Archive; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Anti-Arrhythmia Agents - pharmacology antiarrhythmic agents Antiarythmic agents Benzeneacetamides Biological and medical sciences Cardiac Complexes, Premature - physiopathology cardiac muscle Cardiovascular system Disopyramide - pharmacology Guinea Pigs Heart Conduction System - drug effects Heart Ventricles - drug effects In Vitro Techniques Ion Channels - drug effects Lidocaine - analogs & derivatives Lidocaine - pharmacology Male Medical sciences Mexiletine - pharmacology Papillary Muscles - drug effects Pharmacology. Drug treatments Piperidines - pharmacology sodium Sodium - metabolism |
title | Effect of SUN 1165, a New Potent Antiarrhythmic Agent, on the Kinetics of Rate-Dependent Block of Na Channels and Ventricular Conduction of Extrasystoles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A14%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20SUN%201165,%20a%20New%20Potent%20Antiarrhythmic%20Agent,%20on%20the%20Kinetics%20of%20Rate-Dependent%20Block%20of%20Na%20Channels%20and%20Ventricular%20Conduction%20of%20Extrasystoles&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Hattori,%20Yoshikazu&rft.date=1988-04&rft.volume=11&rft.issue=4&rft.spage=407&rft.epage=412&rft.pages=407-412&rft.issn=0160-2446&rft.eissn=1533-4023&rft.coden=JCPCDT&rft_id=info:doi/10.1097/00005344-198804000-00005&rft_dat=%3Cproquest_cross%3E78236322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15111302&rft_id=info:pmid/2453743&rfr_iscdi=true |